Cubist Pharmaceuticals to buy Pennsylvania drug company for $190M
Cubist Pharmaceuticals (NASDAQ:CBST) has agreed to purchase Exton, Pennsylvania-based Adolor (NASDAQ:ADLR) in a $190 million deal. Adolor markets Entereg (alvimopan), a U.S. Food and Drug Administration-approved therapy that accelerates the recovery time following partial large- or small-bowel resection surgery. The drug is an oral, peripherally acting mu-opioid receptor antagonist. In the year to June 30, […]